I'm LongbridgeAI, I can summarize articles.The Week
3SBIO (1530.HK) fell 4.75% this week to close at HK$14.44, underperforming the Hang Seng Index, which lost 3.32%, by about 1.43 percentage points. The stock opened Monday at the week’s high of HK$15.49 and drifted lower from Tuesday through Thursday, touching a low of HK$14.34 on Thursday before a slight recovery into the close. Weekly amplitude was 7.55%. Average daily volume of around 11.4m shares ran 36% below the 60-day median, indicating thin trading with no major catalyst this week.
Analyst Ratings
Among 14 brokers covering 3SBIO, 9 rate it buy, 4 rate it overweight, and 1 rates it hold; none rate it underweight or sell. The consensus rating is strong buy, with a consensus target of HK$28.94, about 100.4% above the current price of HK$14.44. Individual targets range from HK$17.054 to HK$37.623, a notably wide spread. Within the biotech sector of 52 companies, 3SBIO ranks 7th by analyst rating.
The Week Ahead
Hong Kong’s unemployment rate is due on Tuesday, with a prior reading of 3.9%. 3SBIO reports fiscal Q3 2026 earnings on Wednesday before market open. Hong Kong’s CPI follows on Friday, with a prior reading of 1.9%.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.
